SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
World Health Organization Director-General Tedros Adhanom Ghebreyesus speaks during a press conference on December 20, 2021. (Photo: Fabrice Coffrini/AFP via Getty Images)
'Unprecedented': WHO Chief Urges Moderna Shareholders to Back Vaccine Tech Transfer
The WHO director-general will present a shareholder resolution calling on the pharmaceutical giant to make its coronavirus vaccine recipe available to the world.
Apr 28, 2022
World Health Organization Director-General Tedros Adhanom Ghebreyesus will present a shareholder resolution Thursday calling on the U.S.-based pharmaceutical giant Moderna to make its coronavirus vaccine technology available to the world, a first-of-its-kind move from the U.N. agency as the global pandemic rages on.
"It is an unprecedented appearance for an unprecedented pandemic," Peter Singer, a special adviser to Tedros, told Reuters ahead of Moderna's annual shareholder meeting, where Tedros will present the resolution as vaccine equity campaigners prepare to hold die-ins and other demonstrations at the company's headquarters in Boston.
"It is an unprecedented appearance for an unprecedented pandemic."
Singer said Tedros' presentation will mark the first time the U.N. agency has made such an intervention at a publicly-traded company.
Sponsored by Oxfam America, the resolution calls on Moderna to study "the feasibility of promptly transferring intellectual property and technical knowledge ('know-how') to facilitate the production of Covid-19 vaccine doses by additional qualified manufacturers located in low- and middle-income countries."
Tedros' presentation will come after two of Moderna's largest investors voiced opposition to the shareholder resolution. Moderna's leadership, headed by billionaire CEO Stephane Bancel, has urged shareholders to block the resolution, claiming it would not "address the realities of the pandemic as it exists today."
Public health campaigners strongly disagree, arguing that technology transfer is essential to ensure sufficient vaccine access in low-income nations. To date, just 15.3% of people in low-income countries have received at least one coronavirus vaccine dose.
Moderna's refusal to abandon restrictive patents and share its publicly funded technology with the world has hampered efforts by a WHO-backed hub in South Africa to make an mRNA-based coronavirus vaccine for developing nations.
"It is unacceptable that Moderna has reaped the benefits of public taxpayer money to develop this blockbuster vaccine, yet refuses to share the recipe with producers across the rest of the world that have the capacity to make mRNA vaccines for countries' current and future needs, for both Covid and other diseases," Mihir Mankad, senior global health advocacy and policy adviser at Doctors Without Borders, said in a statement Wednesday.
"Moderna made this lifesaving mRNA vaccine a reality with substantial U.S. government support," Mankad added, "and both parties need to commit to unconditional sharing of the technology for the purposes of pandemic preparedness."
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
World Health Organization Director-General Tedros Adhanom Ghebreyesus will present a shareholder resolution Thursday calling on the U.S.-based pharmaceutical giant Moderna to make its coronavirus vaccine technology available to the world, a first-of-its-kind move from the U.N. agency as the global pandemic rages on.
"It is an unprecedented appearance for an unprecedented pandemic," Peter Singer, a special adviser to Tedros, told Reuters ahead of Moderna's annual shareholder meeting, where Tedros will present the resolution as vaccine equity campaigners prepare to hold die-ins and other demonstrations at the company's headquarters in Boston.
"It is an unprecedented appearance for an unprecedented pandemic."
Singer said Tedros' presentation will mark the first time the U.N. agency has made such an intervention at a publicly-traded company.
Sponsored by Oxfam America, the resolution calls on Moderna to study "the feasibility of promptly transferring intellectual property and technical knowledge ('know-how') to facilitate the production of Covid-19 vaccine doses by additional qualified manufacturers located in low- and middle-income countries."
Tedros' presentation will come after two of Moderna's largest investors voiced opposition to the shareholder resolution. Moderna's leadership, headed by billionaire CEO Stephane Bancel, has urged shareholders to block the resolution, claiming it would not "address the realities of the pandemic as it exists today."
Public health campaigners strongly disagree, arguing that technology transfer is essential to ensure sufficient vaccine access in low-income nations. To date, just 15.3% of people in low-income countries have received at least one coronavirus vaccine dose.
Moderna's refusal to abandon restrictive patents and share its publicly funded technology with the world has hampered efforts by a WHO-backed hub in South Africa to make an mRNA-based coronavirus vaccine for developing nations.
"It is unacceptable that Moderna has reaped the benefits of public taxpayer money to develop this blockbuster vaccine, yet refuses to share the recipe with producers across the rest of the world that have the capacity to make mRNA vaccines for countries' current and future needs, for both Covid and other diseases," Mihir Mankad, senior global health advocacy and policy adviser at Doctors Without Borders, said in a statement Wednesday.
"Moderna made this lifesaving mRNA vaccine a reality with substantial U.S. government support," Mankad added, "and both parties need to commit to unconditional sharing of the technology for the purposes of pandemic preparedness."
From Your Site Articles
World Health Organization Director-General Tedros Adhanom Ghebreyesus will present a shareholder resolution Thursday calling on the U.S.-based pharmaceutical giant Moderna to make its coronavirus vaccine technology available to the world, a first-of-its-kind move from the U.N. agency as the global pandemic rages on.
"It is an unprecedented appearance for an unprecedented pandemic," Peter Singer, a special adviser to Tedros, told Reuters ahead of Moderna's annual shareholder meeting, where Tedros will present the resolution as vaccine equity campaigners prepare to hold die-ins and other demonstrations at the company's headquarters in Boston.
"It is an unprecedented appearance for an unprecedented pandemic."
Singer said Tedros' presentation will mark the first time the U.N. agency has made such an intervention at a publicly-traded company.
Sponsored by Oxfam America, the resolution calls on Moderna to study "the feasibility of promptly transferring intellectual property and technical knowledge ('know-how') to facilitate the production of Covid-19 vaccine doses by additional qualified manufacturers located in low- and middle-income countries."
Tedros' presentation will come after two of Moderna's largest investors voiced opposition to the shareholder resolution. Moderna's leadership, headed by billionaire CEO Stephane Bancel, has urged shareholders to block the resolution, claiming it would not "address the realities of the pandemic as it exists today."
Public health campaigners strongly disagree, arguing that technology transfer is essential to ensure sufficient vaccine access in low-income nations. To date, just 15.3% of people in low-income countries have received at least one coronavirus vaccine dose.
Moderna's refusal to abandon restrictive patents and share its publicly funded technology with the world has hampered efforts by a WHO-backed hub in South Africa to make an mRNA-based coronavirus vaccine for developing nations.
"It is unacceptable that Moderna has reaped the benefits of public taxpayer money to develop this blockbuster vaccine, yet refuses to share the recipe with producers across the rest of the world that have the capacity to make mRNA vaccines for countries' current and future needs, for both Covid and other diseases," Mihir Mankad, senior global health advocacy and policy adviser at Doctors Without Borders, said in a statement Wednesday.
"Moderna made this lifesaving mRNA vaccine a reality with substantial U.S. government support," Mankad added, "and both parties need to commit to unconditional sharing of the technology for the purposes of pandemic preparedness."
From Your Site Articles
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.